Cargando…

Intravitreal bevacizumab upregulates transthyretin in experimental branch retinal vein occlusion

PURPOSE: To identify retinal protein changes that mediate beneficial effects of intravitreal bevacizumab in experimental branch retinal vein occlusion (BRVO). METHODS: In six Danish Landrace pigs, BRVO was induced with argon laser in both eyes. After BRVO was induced, the right eye of each animal wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cehofski, Lasse Jørgensen, Kruse, Anders, Alsing, Alexander Nørgård, Nielsen, Jonas Ellegaard, Pedersen, Shona, Kirkeby, Svend, Honoré, Bent, Vorum, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Vision 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279196/ https://www.ncbi.nlm.nih.gov/pubmed/30581282

Ejemplares similares

Aflibercept Intervention in Experimental Branch Retinal Vein Occlusion Results in Upregulation of DnaJ Homolog Subfamily C Member 17
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2021)

IL-18 and S100A12 Are Upregulated in Experimental Central Retinal Vein Occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2018)

Large-Scale Protein Analysis of Experimental Retinal Artery Occlusion
por: Vestergaard, Nanna, et al.
Publicado: (2023)

Proteome Analysis of Bevacizumab Intervention in Experimental Central Retinal Vein Occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2023)

Dye-Free Porcine Model of Experimental Branch Retinal Vein Occlusion: A Suitable Approach for Retinal Proteomics
por: Jørgensen Cehofski, Lasse, et al.
Publicado: (2015)

A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2017)

Proteome Analysis of Aflibercept Intervention in Experimental Central Retinal Vein Occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2022)

Laser-Induced Porcine Model of Experimental Retinal Vein Occlusion: An Optimized Reproducible Approach
por: Mæng, Mads Odgaard, et al.
Publicado: (2023)

Dexamethasone Intravitreal Implant Is Active at the Molecular Level Eight Weeks after Implantation in Experimental Central Retinal Vein Occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2022)

Animal Models Used to Simulate Retinal Artery Occlusion: A Comprehensive Review
por: Vestergaard, Nanna, et al.
Publicado: (2019)

Aqueous Fibronectin Correlates With Severity of Macular Edema and Visual Acuity in Patients With Branch Retinal Vein Occlusion: A Proteome Study
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2020)

Macular Edema in Central Retinal Vein Occlusion Correlates With Aqueous Fibrinogen Alpha Chain
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2023)

Proteomic Analysis of Tissue from α1,3-galactosyltransferase Knockout Mice Reveals That a Wide Variety of Proteins and Protein Fragments Change Expression Level
por: Thorlacius-Ussing, Louise, et al.
Publicado: (2013)

Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion
por: Deka, Satyen, et al.
Publicado: (2009)

Efficacy of combined intravitreal bevacizumab and triamcinolone for branch retinal vein occlusion
por: Ali, Rasha I, et al.
Publicado: (2014)

Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
por: Demir, Mehmet, et al.
Publicado: (2011)

Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
por: Thapa, Raba, et al.
Publicado: (2012)

Comparison Between Intravitreal Bevacizumab and Triamcinolone for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Kim, Jin Young, et al.
Publicado: (2009)

The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
por: Gokce, Gokcen, et al.
Publicado: (2014)

Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Wang, Jia-Kang, et al.
Publicado: (2016)

Effects of intravitreal bevacizumab on reduced visual acuity and macular thickness secondary to branch retinal vein occlusion
por: Eltutar, Kadir, et al.
Publicado: (2013)

Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion
por: Hikichi, Taiichi, et al.
Publicado: (2014)

Bevacizumab and Triamcinolone for Branch Vein Occlusion
por: Wong, Ian Yat Hin
Publicado: (2010)

Initial Dose of Three Monthly Intravitreal Injections versus PRN Intravitreal Injections of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Ahn, Seong Joon, et al.
Publicado: (2013)

Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
por: Yunoki, Tatsuya, et al.
Publicado: (2013)

Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Lee, Kyou Ho, et al.
Publicado: (2017)

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
por: Jaissle, Gesine B., et al.
Publicado: (2010)

Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion
por: Ito, Yuka, et al.
Publicado: (2015)

Acute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report
por: Jeong, Seongyong, et al.
Publicado: (2017)

Natural Short-term Course of Recurrent Macular Edema Following Intravitreal Bevacizumab Therapy in Branch Retinal Vein Occlusion
por: Yoo, Su Jin, et al.
Publicado: (2017)

OCT angiography features associated with macular edema recurrence after intravitreal bevacizumab treatment in branch retinal vein occlusion
por: Choi, Kwang-Eon, et al.
Publicado: (2019)

Short-term and long-term results after intravitreal bevacizumab therapy for macular oedema in branch retinal vein occlusion
por: Pidro, Ajla, et al.
Publicado: (2022)

Meibomian Gland Dysfunction Is Associated with Low Levels of Immunoglobulin Chains and Cystatin-SN
por: Muttuvelu, Danson Vasanthan, et al.
Publicado: (2023)

The effect of intravitreal bevacizumab on ocular blood flow in diabetic retinopathy and branch retinal vein occlusion as measured by laser speckle flowgraphy
por: Nitta, Fumihiko, et al.
Publicado: (2014)

Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Hirashima, Takafumi, et al.
Publicado: (2014)

Rapid regression of retinal neovascularization following intravitreal bevacizumab in branch retinal vein occlusion imaged by optical coherence tomography angiography
por: Brar, Manpreet, et al.
Publicado: (2018)

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion
por: Kumagai, Kazuyuki, et al.
Publicado: (2019)

Intravitreal bevacizumab
por: Khamar, Bakulesh M
Publicado: (2018)

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
por: Yalamanchi, Shalini, et al.
Publicado: (2011)

Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion
por: Hall, Leangelo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_07mphup5facta713eo6qisg8gq